Previous 10 | Next 10 |
CARLSBAD, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter earnings results after market close on Thursday, February 21, 2019. Management will hold a conference call to review the Company's fi...
NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cummins Inc. (NYSE:CMI), R.R. Donnelley & Sons Company (NYSE:RRD), Ja...
The FDA grants 510(k) clearance for GenMark Diagnostics' (NASDAQ: GNMK ) ePlex Blood Culture Identification Fungal Pathogen (BCID-FP) Panel. More news on: GenMark Diagnostics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Two of Three ePlex Blood Culture Identification Panels Now Cleared for Marketing in the U.S. CARLSBAD, Calif., Dec. 26, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced t...
NEW YORK, Nov. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hess Midstream Partners LP (NYSE:HESM), Quanta Services, Inc. (NYSE:PWR),...
GenMark Diagnostics, Inc. (GNMK) Q3 2018 Earnings Conference Call October 29, 2018 04:30 PM ET Executives Johnny Ek - Corporate Controller Hany Massarany - President & CEO Scott Mendel - CFO Analysts Mark Massaro - Canaccord Doug Schenkel - Cowen Tycho Peterson - ...
GenMark Diagnostics (NASDAQ: GNMK ): Q3 GAAP EPS of -$0.20 in-line. More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
CARLSBAD, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the third quarter ended September 30, 2018. Highlights Recognized reve...
CARLSBAD, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Monday, October 29, 2018. Management will hold a conference call to review the Company's financ...
NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of PTC Inc. (NASDAQ:PTC), H&R Block, Inc. (NYSE:HRB), GenMark Diagnos...
News, Short Squeeze, Breakout and More Instantly...
GenMark Diagnostics Inc. Company Name:
GNMK Stock Symbol:
NASDAQ Market:
GenMark Diagnostics Inc. Website:
NEW YORK, NY / ACCESSWIRE / April 9, 2021 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New ...
Healthcare giant Roche Holding (OTC: RHHBY) recently announced plans to acquire GenMark Diagnostics (NASDAQ: GNMK) in a deal valued at around $1.8 billion. The news sent GenMark's shares soaring close to 30%. In this Motley Fool Live video, recorded on March 17 , Mot...
USA News Group / In the wake of the US presidential election, calls for economies to reopen are beginning to mount from governors such as Andrew Cuomo in New York and Gavin Newsom in California , and mayors like Chicago’s Lori Lightfoot. As regulators contemplate the ...